Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
TBCRC030 - A Randomized Phase II Study of Preoperative Cisplatin versus Paclitaxel in Patients with Triple Negative Breast Cancer: Evaluating the Homologous Recombination Deficiency (HRD) Biomarker
Grant
Overview
Affiliation
Overview
Awarded By
Johns Hopkins University
Total Award Amount
87926.00
Direct Costs
69783.00
Sponsor Award Id
Affiliation
Contributor
Erica Stringer-Reasor M.D.
Investigator
Gabrielle Rocque M.D.
Investigator
Lisle Nabell M.D.
Investigator